Shah wins AHA/ASA Stroke Care Award
The American Heart Association/American Stroke Association (AHA/ASA) has awarded Shreyansh Shah, MD the “Stroke Care in Emergency Medicine” award for his research examining use of intravenous tissue Plasminogen Activator (tPA) in stroke patients with recent history of ischemic stroke. Ying Xian, MD, PhD is the senior author on this research project which is titled “Safety and outcomes of intravenous tissue plasminogen activator in acute ischemic stroke patients with recent stroke: Findings from Get with the Guidelines-Stroke.” This research project was funded by an AHA/ASA research grant to Xian to evaluate safety profile of “off-label” thrombolysis. Shah will deliver a platform presentation detailing the study at the upcoming International Stroke Conference in Honolulu this February.
The International Stroke Conference (ISC) is the world’s premier meeting dedicated to the science and treatment of cerebrovascular disease. This 2½-day conference features more than 1,600 compelling presentations in 21 categories that emphasize basic, clinical and translational sciences. “Stroke Care in Emergency Medicine” is an annual award given at the conference to investigators doing research in the emergent phase of acute stroke treatment. Read more about ISC 2019 here.